BIOGEN INC. Increase (Decrease) in Inventories
BIOGEN INC. (BIIB) reported Increase (Decrease) in Inventories of -$116.20 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-04-29
- BIOGEN INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$116.20M.
- BIOGEN INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $29.40M, a 55.72% decline year-over-year.
- BIOGEN INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $7.40M, a 61.46% decline year-over-year.
- BIOGEN INC. increase (decrease) in inventories for the quarter ending 2025-06-30 was $89.90M, a 18.64% decline year-over-year.
- BIOGEN INC. increase (decrease) in inventories for fiscal 2025 was $64.70M, a 76.37% decline from fiscal 2024.
- BIOGEN INC. increase (decrease) in inventories for fiscal 2024 was $273.80M, a 109.17% increase from fiscal 2023.
- BIOGEN INC. increase (decrease) in inventories for fiscal 2023 was $130.90M, a 59.12% decline from fiscal 2022.
- BIOGEN INC. increase (decrease) in inventories for fiscal 2022 was $320.20M, a 30.75% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$116.20M 10-Q · filed 2026-04-29 | -$86.80M derived: sum of 2 quarters · filed 2026-04-29 | -$79.40M derived: sum of 3 quarters · filed 2026-04-29 | $10.50M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | $29.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $36.80M derived: sum of 2 quarters · filed 2026-02-06 | $126.70M derived: sum of 3 quarters · filed 2026-02-06 | $64.70M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $97.30M derived: sum of 2 quarters · filed 2025-10-30 | $35.30M 10-Q · filed 2025-10-30 | $101.70M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | $89.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $27.90M 10-Q · filed 2025-07-31 | $94.30M derived: sum of 3 quarters · filed 2026-04-29 | $113.50M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | -$62.00M 10-Q · filed 2026-04-29 | $4.40M derived: sum of 2 quarters · filed 2026-04-29 | $23.60M derived: sum of 3 quarters · filed 2026-04-29 | $134.10M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $66.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $85.60M derived: sum of 2 quarters · filed 2026-02-06 | $196.10M derived: sum of 3 quarters · filed 2026-02-06 | $273.80M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | $19.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $129.70M derived: sum of 2 quarters · filed 2025-10-30 | $207.40M 10-Q · filed 2025-10-30 | $303.40M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | $110.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $188.20M 10-Q · filed 2025-07-31 | $284.20M derived: sum of 3 quarters · filed 2026-02-06 | $254.00M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | $77.70M 10-Q · filed 2025-05-01 | $173.70M derived: sum of 2 quarters · filed 2026-02-06 | $143.50M derived: sum of 3 quarters · filed 2026-02-06 | $236.50M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | $96.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $65.80M derived: sum of 2 quarters · filed 2026-02-06 | $158.80M derived: sum of 3 quarters · filed 2026-02-06 | $130.90M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | -$30.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $62.80M derived: sum of 2 quarters · filed 2024-10-30 | $34.90M 10-Q · filed 2024-10-30 | $16.80M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $93.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $65.10M 10-Q · filed 2024-08-01 | $47.00M derived: sum of 3 quarters · filed 2025-02-12 | $142.00M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | -$27.90M 10-Q · filed 2024-04-24 | -$46.00M derived: sum of 2 quarters · filed 2025-02-12 | $49.00M derived: sum of 3 quarters · filed 2025-02-12 | $149.70M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | -$18.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $76.90M derived: sum of 2 quarters · filed 2025-02-12 | $177.60M derived: sum of 3 quarters · filed 2025-02-12 | $320.20M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $95.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $195.70M derived: sum of 2 quarters · filed 2023-11-08 | $338.30M 10-Q · filed 2023-11-08 | $478.10M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $100.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $243.30M 10-Q · filed 2023-07-25 | $383.10M derived: sum of 3 quarters · filed 2024-02-14 | $511.90M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $142.60M 10-Q · filed 2023-04-25 | $282.40M derived: sum of 2 quarters · filed 2024-02-14 | $411.20M derived: sum of 3 quarters · filed 2024-02-14 | $492.50M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $139.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $268.60M derived: sum of 2 quarters · filed 2024-02-14 | $349.90M derived: sum of 3 quarters · filed 2024-02-14 | $462.40M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | $128.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $210.10M derived: sum of 2 quarters · filed 2022-10-25 | $322.60M 10-Q · filed 2022-10-25 | $368.30M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $81.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | $193.80M 10-Q · filed 2022-07-20 | $239.50M derived: sum of 3 quarters · filed 2023-02-15 | $321.90M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $112.50M 10-Q · filed 2022-05-03 | $158.20M derived: sum of 2 quarters · filed 2023-02-15 | $240.60M derived: sum of 3 quarters · filed 2023-02-15 | $366.60M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | $45.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $128.10M derived: sum of 2 quarters · filed 2023-02-15 | $254.10M derived: sum of 3 quarters · filed 2023-02-15 | $316.30M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $82.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $208.40M derived: sum of 2 quarters · filed 2021-10-20 | $270.60M 10-Q · filed 2021-10-20 | $337.10M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $126.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | $188.20M 10-Q · filed 2021-07-22 | $254.70M derived: sum of 3 quarters · filed 2022-02-03 | $316.10M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | $62.20M 10-Q · filed 2021-04-22 | $128.70M derived: sum of 2 quarters · filed 2022-02-03 | $190.10M derived: sum of 3 quarters · filed 2022-02-03 | $210.40M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $66.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $127.90M derived: sum of 2 quarters · filed 2022-02-03 | $148.20M derived: sum of 3 quarters · filed 2022-02-03 | $19.20M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $61.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | $81.70M derived: sum of 2 quarters · filed 2020-10-21 | -$47.30M 10-Q · filed 2020-10-21 | -$27.10M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | $20.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | -$108.70M 10-Q · filed 2020-07-22 | -$88.50M derived: sum of 3 quarters · filed 2021-02-03 | -$96.70M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | -$129.00M 10-Q · filed 2020-04-23 | -$108.80M derived: sum of 2 quarters · filed 2021-02-03 | -$117.00M derived: sum of 3 quarters · filed 2021-02-03 | -$74.30M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | $20.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $12.00M derived: sum of 2 quarters · filed 2021-02-03 | $54.70M derived: sum of 3 quarters · filed 2021-02-03 | $52.10M 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | -$8.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | $34.50M derived: sum of 2 quarters · filed 2019-10-22 | $31.90M 10-Q · filed 2019-10-22 | -$43.90M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | $42.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $40.10M 10-Q · filed 2019-07-24 | -$35.70M derived: sum of 3 quarters · filed 2020-02-06 | $49.30M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | -$2.60M 10-Q · filed 2019-04-24 | -$78.40M derived: sum of 2 quarters · filed 2020-02-06 | $6.60M derived: sum of 3 quarters · filed 2020-02-06 | $45.70M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | -$75.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $9.20M derived: sum of 2 quarters · filed 2020-02-06 | $48.30M derived: sum of 3 quarters · filed 2020-02-06 | $94.50M 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | $85.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $124.10M derived: sum of 2 quarters · filed 2018-10-23 | $170.30M 10-Q · filed 2018-10-23 | $180.80M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | $39.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | $85.30M 10-Q · filed 2018-07-24 | $95.80M derived: sum of 3 quarters · filed 2019-02-06 | $122.60M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | $46.20M 10-Q · filed 2018-04-24 | $56.70M derived: sum of 2 quarters · filed 2019-02-06 | $83.50M derived: sum of 3 quarters · filed 2019-02-06 | $123.20M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | $10.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $37.30M derived: sum of 2 quarters · filed 2019-02-06 | $77.00M derived: sum of 3 quarters · filed 2019-02-06 | $165.60M 10-K · filed 2019-02-06 | ||||
| 2016-09-30 | $26.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | $66.50M derived: sum of 2 quarters · filed 2017-10-24 | $155.10M 10-Q · filed 2017-10-24 | $179.10M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | $39.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $128.30M 10-Q · filed 2017-07-25 | $152.30M derived: sum of 3 quarters · filed 2018-02-01 | $221.40M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $88.60M 10-Q · filed 2017-04-25 | $112.60M derived: sum of 2 quarters · filed 2018-02-01 | $181.70M derived: sum of 3 quarters · filed 2018-02-01 | $241.50M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $93.10M derived: sum of 2 quarters · filed 2018-02-01 | $152.90M derived: sum of 3 quarters · filed 2018-02-01 | $174.40M 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | $69.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | $128.90M derived: sum of 2 quarters · filed 2016-10-26 | $150.40M 10-Q · filed 2016-10-26 | $150.39M 10-Q · filed 2015-10-21 | $216.41M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-06-30 | $59.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | $81.30M 10-Q · filed 2016-07-21 | $81.29M 10-Q · filed 2015-07-24 | $147.31M derived: sum of 3 quarters · filed 2017-02-02 | $194.51M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-03-31 | $21.50M 10-Q · filed 2016-04-21 | $21.51M 10-Q · filed 2015-04-24 | $87.51M derived: sum of 2 quarters · filed 2017-02-02 | $134.71M derived: sum of 3 quarters · filed 2017-02-02 | $190.42M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $66.01M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $113.21M derived: sum of 2 quarters · filed 2017-02-02 | $168.92M derived: sum of 3 quarters · filed 2017-02-02 | $185.90M 10-K · filed 2017-02-02 | $185.92M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | $47.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | $102.91M derived: sum of 2 quarters · filed 2015-10-21 | $119.89M 10-Q · filed 2015-10-21 | $180.98M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | $55.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | $72.69M 10-Q · filed 2015-07-24 | $133.78M derived: sum of 3 quarters · filed 2016-02-03 | $187.42M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $16.98M 10-Q · filed 2015-04-24 | $78.07M derived: sum of 2 quarters · filed 2016-02-03 | $131.71M derived: sum of 3 quarters · filed 2016-02-03 | $200.07M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | $61.09M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $114.73M derived: sum of 2 quarters · filed 2016-02-03 | $183.09M derived: sum of 3 quarters · filed 2016-02-03 | $243.90M 10-K · filed 2016-02-03 | $243.96M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $53.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | $122.00M derived: sum of 2 quarters · filed 2014-10-22 | $182.81M 10-Q · filed 2014-10-22 | $240.70M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | $68.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | $129.17M 10-Q · filed 2014-07-23 | $187.06M derived: sum of 3 quarters · filed 2015-02-04 | $225.12M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | $60.81M 10-Q · filed 2014-04-23 | $118.69M derived: sum of 2 quarters · filed 2015-02-04 | $156.75M derived: sum of 3 quarters · filed 2015-02-04 | $182.09M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | $57.89M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $95.95M derived: sum of 2 quarters · filed 2015-02-04 | $121.28M derived: sum of 3 quarters · filed 2015-02-04 | $140.31M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | $38.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $63.40M derived: sum of 2 quarters · filed 2013-10-28 | $82.42M 10-Q · filed 2013-10-28 | $105.88M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | $25.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $44.36M 10-Q · filed 2013-07-25 | $67.81M derived: sum of 3 quarters · filed 2014-02-06 | $78.87M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $19.03M 10-Q · filed 2013-04-25 | $42.48M derived: sum of 2 quarters · filed 2014-02-06 | $53.54M derived: sum of 3 quarters · filed 2014-02-06 | $71.75M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | $23.45M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $34.51M derived: sum of 2 quarters · filed 2014-02-06 | $52.72M derived: sum of 3 quarters · filed 2014-02-06 | $59.22M 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | $11.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | $29.27M derived: sum of 2 quarters · filed 2012-10-25 | $35.77M 10-Q · filed 2012-10-25 | $56.60M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-06-30 | $18.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-26 | $24.71M 10-Q · filed 2011-07-26 | $45.55M derived: sum of 3 quarters · filed 2013-02-05 | $50.68M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-03-31 | $6.50M 10-Q · filed 2011-04-21 | $27.34M derived: sum of 2 quarters · filed 2013-02-05 | $32.47M derived: sum of 3 quarters · filed 2013-02-05 | $23.29M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2010-12-31 | $20.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | $25.97M derived: sum of 2 quarters · filed 2013-02-05 | $16.79M derived: sum of 3 quarters · filed 2013-02-05 | $4.53M 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | $5.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$4.05M derived: sum of 2 quarters · filed 2011-10-28 | -$16.31M 10-Q · filed 2011-10-28 | $1.27M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-06-30 | -$9.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-26 | -$21.45M 10-Q · filed 2011-07-26 | -$3.87M derived: sum of 3 quarters · filed 2012-02-03 | $6.97M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-03-31 | -$12.26M 10-Q · filed 2011-04-21 | $12.26M 10-Q · filed 2010-04-20 | $5.31M derived: sum of 2 quarters · filed 2012-02-03 | $16.16M derived: sum of 3 quarters · filed 2012-02-03 | $43.23M derived: sum of 4 quarters · filed 2012-02-03 | |||
| 2009-12-31 | $17.58M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | $28.42M derived: sum of 2 quarters · filed 2012-02-03 | $55.49M derived: sum of 3 quarters · filed 2012-02-03 | $42.77M 10-K · filed 2012-02-03 | -$42.77M 10-K · filed 2010-02-09 | |||
| 2009-09-30 | $10.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $37.91M derived: sum of 2 quarters · filed 2010-10-26 | $25.20M 10-Q · filed 2010-10-26 | -$25.20M 10-Q · filed 2009-10-21 | $113.78M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-06-30 | $27.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-20 | $14.35M 10-Q · filed 2010-07-20 | -$14.35M 10-Q · filed 2009-07-17 | $102.93M derived: sum of 3 quarters · filed 2011-02-04 | $96.74M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-03-31 | -$12.72M 10-Q · filed 2010-04-20 | $75.86M derived: sum of 2 quarters · filed 2011-02-04 | $69.67M derived: sum of 3 quarters · filed 2011-02-04 | |||||
| 2008-12-31 | $88.58M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | $82.39M derived: sum of 2 quarters · filed 2011-02-04 | $54.20M 10-K · filed 2011-02-04 | -$54.20M 10-K · filed 2010-02-09 | ||||
| 2008-09-30 | -$6.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21 | -$34.38M 10-Q · filed 2009-10-21 | ||||||
| 2008-06-30 | -$28.19M 10-Q · filed 2009-07-17 | |||||||
| 2007-12-31 | -$83.19M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |